CLO22-068: An Assessment of Extended Pembrolizumab Dosing and Outcomes in Advanced Non-Small Cell Lung Cancer Patients During the COVID-19 Pandemic

Authors:
Gordon Taylor Moffat Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Gordon Taylor Moffat in
Current site
Google Scholar
PubMed
Close
 MD
,
Lilian Hanna Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Lilian Hanna in
Current site
Google Scholar
PubMed
Close
 DO
,
Wilma Hopman Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Wilma Hopman in
Current site
Google Scholar
PubMed
Close
 BA, MA
,
Andrea S. Fung Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Andrea S. Fung in
Current site
Google Scholar
PubMed
Close
 MD, PhD
, and
Pierre-Olivier Gaudreau Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada
Canadian Cancer Trials Group, Queen’s University, Kingston, Ontario, Canada

Search for other papers by Pierre-Olivier Gaudreau in
Current site
Google Scholar
PubMed
Close
 MD, PhD
Restricted access

Corresponding Author: Gordon Taylor Moffat, MD
  • Collapse
  • Expand
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 378 150 0
PDF Downloads 0 0 0
EPUB Downloads 0 0 0